- Market Watch7 days ago
Seal Rock Therapeutics Advancing Differentiated ASK1 Inhibitor Lead Candidate SRT-015 in Nonalcoholic Steatohepatitis (NASH)Market Watch5 days ago
Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon(TM) Endocrinology Rare Disease...Market Watch6 days ago
Our Business Takeda continues its transformation into an agile and innovative global pharmaceutical leader, serving the needs of patients and physicians worldwide. Learn more
Takeda Pharmaceuticals International, Inc company research & investing information. Find executives and the latest company news.
Get to know Takeda Pharmaceuticals International, Inc CEO & other corporate executives. Learn about the Board of Directors, Executive Committees and CEO compensation in this industry.
Drugs Associated with Takeda Pharmaceuticals U.S.A., Inc. Takeda Pharmaceuticals U.S.A., Inc. manufactures, markets and/or distributes more than 24 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region ...
Takeda Pharmaceuticals International, Inc. is a Georgia Foreign Profit Corporation filed on March 2, 2012. The company's filing status is listed as Active/Compliance and its File Number is 12021256.
TAKEDA PHARMACEUTICALS INTERNATIONAL, INC. is an entity registered at California with company number C3446783. Company is incorporated on 1st March 2012. Current status of the company is ACTIVE.
Jonathan Lanfear is the Vice President and Global Head of Oncology & Neuroscience Business Development at Takeda Pharmaceuticals International and is based in Cambridge, MA.
Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社, Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue.
At Takeda Oncology, the oncology business unit brand of Takeda Pharmaceutical Company Limited, we endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients.
- related to TAKEDA PHARMACEUTICALS INTERNATIONAL, INC